189 related articles for article (PubMed ID: 27015260)
1. A Randomized Trial of Human Papillomavirus Self-Sampling as an Intervention to Promote Cervical Cancer Screening Among Women With HIV.
Murphy J; Mark H; Anderson J; Farley J; Allen J
J Low Genit Tract Dis; 2016 Apr; 20(2):139-44. PubMed ID: 27015260
[TBL] [Abstract][Full Text] [Related]
2. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
3. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.
Balasubramanian A; Kulasingam SL; Baer A; Hughes JP; Myers ER; Mao C; Kiviat NB; Koutsky LA
J Low Genit Tract Dis; 2010 Jul; 14(3):185-95. PubMed ID: 20592553
[TBL] [Abstract][Full Text] [Related]
4. Effect of Educational Intervention on Self-Sampling Acceptability and Follow-Up Paps in Border Dwelling Hispanic Females.
Molokwu JC; Penaranda E; Dwivedi A; Mallawaarachchi I; Shokar N
J Low Genit Tract Dis; 2018 Oct; 22(4):295-301. PubMed ID: 30138152
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U
BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432
[TBL] [Abstract][Full Text] [Related]
6. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
[TBL] [Abstract][Full Text] [Related]
7. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon.
Sossauer G; Zbinden M; Tebeu PM; Fosso GK; Untiet S; Vassilakos P; Petignat P
PLoS One; 2014; 9(10):e109788. PubMed ID: 25333793
[TBL] [Abstract][Full Text] [Related]
8. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening.
Darlin L; Borgfeldt C; Forslund O; Hénic E; Hortlund M; Dillner J; Kannisto P
J Clin Virol; 2013 Sep; 58(1):155-60. PubMed ID: 23867008
[TBL] [Abstract][Full Text] [Related]
9. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
10. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
11. Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland.
Duke P; Godwin M; Ratnam S; Dawson L; Fontaine D; Lear A; Traverso-Yepez M; Graham W; Ravalia M; Mugford G; Pike A; Fortier J; Peach M
BMC Womens Health; 2015 Jun; 15():47. PubMed ID: 26060041
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
13. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.
Gök M; Heideman DA; van Kemenade FJ; Berkhof J; Rozendaal L; Spruyt JW; Voorhorst F; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
BMJ; 2010 Mar; 340():c1040. PubMed ID: 20223872
[TBL] [Abstract][Full Text] [Related]
14. Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial.
Kobetz E; Seay J; Amofah A; Pierre L; Bispo JB; Trevil D; Gonzalez M; Poitevien M; Koru-Sengul T; Carrasquillo O
Trials; 2017 Jan; 18(1):19. PubMed ID: 28086983
[TBL] [Abstract][Full Text] [Related]
15. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
16. Women's Attitudes Toward Cervicovaginal Self-Sampling for High-Risk HPV Infection on the US-Mexico Border.
Penaranda E; Molokwu J; Flores S; Byrd T; Brown L; Shokar N
J Low Genit Tract Dis; 2015 Oct; 19(4):323-8. PubMed ID: 26360234
[TBL] [Abstract][Full Text] [Related]
17. Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial.
Spees LP; Des Marais AC; Wheeler SB; Hudgens MG; Doughty S; Brewer NT; Smith JS
Trials; 2019 Dec; 20(1):788. PubMed ID: 31881928
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
[TBL] [Abstract][Full Text] [Related]
19. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.
Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Jaspars LH; Voorhorst FJ; Verheijen RH; Meijer CJ
J Clin Pathol; 2002 Jun; 55(6):435-9. PubMed ID: 12037026
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.
Sewali B; Okuyemi KS; Askhir A; Belinson J; Vogel RI; Joseph A; Ghebre RG
Cancer Med; 2015 Apr; 4(4):620-31. PubMed ID: 25653188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]